IMU is using the current VAXINIA clinical trial to demonstrate safety as the primary end point and then efficacy as secondary for multiple solid tumours, expansion to other indication like they did for bile duct and recent hint of possible bladder solid cancer market means they see efficacy and more importantly the FDA see safety foremost and then efficacy to allow the clinical trial expansion to start with the highest dosage. This was how IMU received Fast Track designation for Bile duct.
IMU is using the current VAXINIA clinical trial to demonstrate...
-
- There are more pages in this discussion • 1,786 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $334.7M | |||
| Open | High | Low | Value | Volume |
| 4.6¢ | 4.6¢ | 4.4¢ | $417.0K | 9.281M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 6074903 | 4.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 362283 | 5 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |